Study Summary
This trial is testing a vaccine for safety and how the body reacts to it.
- Epstein-Barr Virus (EBV) Infection
Treatment Effectiveness
Effectiveness Progress
Study Objectives
4 Primary · 3 Secondary · Reporting Duration: Days 1, 85, and 197
Trial Safety
Safety Progress
Trial Design
4 Treatment Groups
mRNA-1189 Dose Level 2
1 of 4
mRNA-1189 Dose Level 1
1 of 4
mRNA-1189 Dose Level 3
1 of 4
Placebo
1 of 4
Experimental Treatment
Non-Treatment Group
272 Total Participants · 4 Treatment Groups
Primary Treatment: mRNA-1189 · Has Placebo Group · Phase 1
Trial Logistics
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 30 · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Texas | 35.5% |
| California | 22.6% |
| Oklahoma | 6.5% |
| Other | 35.5% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| Meridian Clinical Research-(Omaha Nebraska) - Platinum - PPDS | 9.1% |
| Fomat Medical Research | 13.6% |
| Smart Cures Clinical Research | 22.7% |
| Other | 54.5% |
What portion of applicants met pre-screening criteria?
| Did not meet criteria | 48.5% |
| Met criteria | 51.5% |
Why did patients apply to this trial?
- "I want money"
- "An ad on Facebook"
- "To see if I have EPV"
- "I think vaccines are important"
- "I had mononucleosis in the past."
How many prior treatments have patients received?
| 0 | 92.9% |
| 2 | 7.1% |
What questions have other patients asked about this trial?
- "How much is compensation?"
- "How much do you pay for it?"
How responsive is this trial?
Average response time
- < 2 Days
Typically responds via
| Phone Call | 50.0% |
| 50.0% | |
Most responsive sites:
- Lynn Health Science Institute: < 48 hours
- Fomat Medical Research: < 48 hours
Frequently Asked Questions
Are seniors eligible to join this clinical experimentation?
"The inclusionary parameters for this medical study specify that applicants should be between the ages 18 to 30. There are 19 trials available for minors and 29 research opportunities specifically catered towards seniors." - Anonymous Online Contributor
How many venues are hosting this clinical exploration?
"Currently, recruitment for this trial is taking place at 34 sites throughout the United States. There are locations in Colton, Houston and Minneapolis as well as various other cities. To reduce travel demands associated with enrolment it may be beneficial to select a clinic near your area of residence." - Anonymous Online Contributor
Who is eligible to partake in this scientific investigation?
"This clinical trial seeks to recruit 272 individuals aged 18-30 that have Epstein Barr Virus. To qualify, participants must display good general health and a BMI of 18-35 kg/m^2 on the Day 0 screening visit." - Anonymous Online Contributor
Has the FDA sanctioned the use of mRNA-1189?
"The safety profile of mRNA-1189 was assigned a score of 1 due to the few preclinical and clinical studies available for this experimental medicinal product." - Anonymous Online Contributor
Is there still capacity for more participants in this research?
"According to clinicaltrials.gov, this trial is currently recruiting volunteers. Initially posted on December 28th 2021, the study was most recently updated on November 21st 2022." - Anonymous Online Contributor
Are there any limits to the amount of participants in this clinical experiment?
"Affirmative. Clinicaltrials.gov confirms that this clinical trial is actively enrolling patients, with the original post made on December 28th 2021 and most recently modified on November 21st 2022. In total, 272 participants need to be recruited from 34 different locations for the study's completion." - Anonymous Online Contributor